 |
|
|
|
Please log in to determine if you are eligible to purchase PT Programs.
|
|
| RNA FUSIONS, SOLID TUMOR - RNA |
RNA
Analytes/procedures in bold type are regulated for proficiency testing by the Centers for Medicare & Medicaid Services (CMS).
Additional Information
- Total RNA from a cell line engineered to contain desired fusion RNA
- This is for laboratories using RNAseq to detect gene fusion transcripts
- This is not intended to replace the current program (SARC) for reverse transcription (RT)-PCR based detection
- Potential fusion variants include CD74e::ROS1, EML4::ALK, ETV6::NTRK3, FGFR3::TACC3, PAX8::PPARG, and SLC45A3::BRAF
- Specific intragenic fusion/exon skipping variants may also be included, specifically EGFRvIII and MET exon 14 skipping.
Program Information
- Three 500-ng RNA (20 ng/μL) specimens
Shipping Schedule
- Shipment A: March 16
- Shipment B: August 10
|
|
|
|
|
|
Help